AABB Applauds FDA’s Final Guidance Recommending Individual Donor Assessment for Blood Donor Eligibility

BETHESDA, Md., May 11, 2023 /PRNewswire/ — The Association for the Advancement of Blood & Biotherapies (AABB) applauds the Food and Drug Administration (FDA) for issuing a final guidance that recommends determining blood donor eligibility based on an individual assessment. Therefore, every prospective donor, regardless of gender or sexual orientation, will be evaluated using the … Read more